These findings suggest that TAT‐Gap19 effectively mitigates BBB impairment in TLE mice without downregulation of Cx43 expression, thus implicating Cx43 HCs in the regulation of BBB permeability during epilepsy. The gene discussed is GJA1; the disease is epilepsy.